vs
Clearfield, Inc.（CLFD）与null（EDIT）财务数据对比。点击上方公司名可切换其他公司
Clearfield, Inc.的季度营收约是null的1.4倍（$34.3M vs $24.7M），Clearfield, Inc.净利率更高（-1.8% vs -22.7%，领先20.9%），Clearfield, Inc.同比增速更快（-3.2% vs -19.2%），Clearfield, Inc.自由现金流更多（$-2.4M vs $-36.4M），过去两年null的营收复合增速更高（366.9% vs -3.5%）
Clearfield, Inc.总部位于美国明尼苏达州明尼阿波利斯市，是一家专注于光纤产品研发生产的企业，其产品主要应用于光纤通信网络建设领域，为通信基础设施部署提供相关硬件支撑。
Editas Medicine是一家处于临床阶段的生物技术企业，总部位于马萨诸塞州剑桥市，在科罗拉多州博尔德市也设有研发场地，目前公司依托CRISPR基因编辑技术，开发针对罕见疾病的治疗方案。
CLFD vs EDIT — 直观对比
营收规模更大
CLFD
是对方的1.4倍
$24.7M
营收增速更快
CLFD
高出16.0%
-19.2%
净利率更高
CLFD
高出20.9%
-22.7%
自由现金流更多
CLFD
多$34.0M
$-36.4M
两年增速更快
EDIT
近两年复合增速
-3.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $34.3M | $24.7M |
| 净利润 | $-614.0K | $-5.6M |
| 毛利率 | 33.2% | — |
| 营业利润率 | -5.3% | -31.3% |
| 净利率 | -1.8% | -22.7% |
| 营收同比 | -3.2% | -19.2% |
| 净利润同比 | 67.8% | 87.6% |
| 每股收益（稀释后） | $-0.04 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLFDEDIT
| Q4 25 | $34.3M | $24.7M | ||
| Q3 25 | $23.4M | $7.5M | ||
| Q2 25 | $49.9M | $3.6M | ||
| Q1 25 | $47.2M | $4.7M | ||
| Q4 24 | $29.7M | $30.6M | ||
| Q3 24 | $5.6M | $61.0K | ||
| Q2 24 | $48.8M | $513.0K | ||
| Q1 24 | $36.9M | $1.1M |
净利润CLFDEDIT
| Q4 25 | $-614.0K | $-5.6M | ||
| Q3 25 | $-9.1M | $-25.1M | ||
| Q2 25 | $1.6M | $-53.2M | ||
| Q1 25 | $1.3M | $-76.1M | ||
| Q4 24 | $-1.9M | $-45.4M | ||
| Q3 24 | — | $-62.1M | ||
| Q2 24 | $-447.0K | $-67.6M | ||
| Q1 24 | $-5.9M | $-62.0M |
毛利率CLFDEDIT
| Q4 25 | 33.2% | — | ||
| Q3 25 | 53.2% | — | ||
| Q2 25 | 30.5% | — | ||
| Q1 25 | 30.1% | — | ||
| Q4 24 | 29.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 21.9% | — | ||
| Q1 24 | 7.7% | — |
营业利润率CLFDEDIT
| Q4 25 | -5.3% | -31.3% | ||
| Q3 25 | 10.3% | -325.4% | ||
| Q2 25 | 3.0% | -1440.6% | ||
| Q1 25 | 0.6% | -1635.1% | ||
| Q4 24 | -6.9% | -152.2% | ||
| Q3 24 | — | -107649.2% | ||
| Q2 24 | -4.7% | -14016.2% | ||
| Q1 24 | -26.4% | -5902.3% |
净利率CLFDEDIT
| Q4 25 | -1.8% | -22.7% | ||
| Q3 25 | -38.8% | -333.0% | ||
| Q2 25 | 3.2% | -1487.8% | ||
| Q1 25 | 2.8% | -1633.5% | ||
| Q4 24 | -6.4% | -148.3% | ||
| Q3 24 | — | -101870.5% | ||
| Q2 24 | -0.9% | -13178.8% | ||
| Q1 24 | -16.0% | -5458.1% |
每股收益（稀释后）CLFDEDIT
| Q4 25 | $-0.04 | $0.03 | ||
| Q3 25 | $-0.65 | $-0.28 | ||
| Q2 25 | $0.11 | $-0.63 | ||
| Q1 25 | $0.09 | $-0.92 | ||
| Q4 24 | $-0.13 | $-0.55 | ||
| Q3 24 | — | $-0.75 | ||
| Q2 24 | $-0.04 | $-0.82 | ||
| Q1 24 | $-0.40 | $-0.76 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $96.4M | $146.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $249.7M | $27.3M |
| 总资产 | $268.1M | $186.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLFDEDIT
| Q4 25 | $96.4M | $146.6M | ||
| Q3 25 | $106.0M | $165.6M | ||
| Q2 25 | $117.2M | $178.5M | ||
| Q1 25 | $112.0M | $221.0M | ||
| Q4 24 | $113.0M | $269.9M | ||
| Q3 24 | $129.0M | $265.1M | ||
| Q2 24 | $123.8M | $279.1M | ||
| Q1 24 | $142.9M | $296.2M |
总债务CLFDEDIT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $57.4M | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | — |
股东权益CLFDEDIT
| Q4 25 | $249.7M | $27.3M | ||
| Q3 25 | $256.2M | $13.5M | ||
| Q2 25 | $264.5M | $19.2M | ||
| Q1 25 | $265.9M | $62.4M | ||
| Q4 24 | $267.4M | $134.3M | ||
| Q3 24 | $275.8M | $175.6M | ||
| Q2 24 | $274.6M | $232.0M | ||
| Q1 24 | $279.2M | $294.4M |
总资产CLFDEDIT
| Q4 25 | $268.1M | $186.5M | ||
| Q3 25 | $306.2M | $201.8M | ||
| Q2 25 | $314.7M | $210.6M | ||
| Q1 25 | $310.9M | $263.7M | ||
| Q4 24 | $303.2M | $341.6M | ||
| Q3 24 | $315.3M | $327.6M | ||
| Q2 24 | $318.1M | $384.8M | ||
| Q1 24 | $315.4M | $440.3M |
负债/权益比CLFDEDIT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.4M | $-36.4M |
| 自由现金流经营现金流 - 资本支出 | $-2.4M | $-36.4M |
| 自由现金流率自由现金流/营收 | -7.1% | -147.3% |
| 资本支出强度资本支出/营收 | 2.9% | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CLFDEDIT
| Q4 25 | $-1.4M | $-36.4M | ||
| Q3 25 | — | $-30.8M | ||
| Q2 25 | $7.9M | $-50.2M | ||
| Q1 25 | $3.0M | $-47.8M | ||
| Q4 24 | $7.2M | $-50.8M | ||
| Q3 24 | $22.2M | $-52.6M | ||
| Q2 24 | $4.0M | $-57.1M | ||
| Q1 24 | $-5.7M | $-49.9M |
自由现金流CLFDEDIT
| Q4 25 | $-2.4M | $-36.4M | ||
| Q3 25 | — | $-31.3M | ||
| Q2 25 | $7.5M | — | ||
| Q1 25 | $654.0K | $-47.9M | ||
| Q4 24 | $5.1M | $-51.3M | ||
| Q3 24 | $18.2M | $-55.5M | ||
| Q2 24 | $2.8M | $-60.6M | ||
| Q1 24 | $-7.7M | $-51.7M |
自由现金流率CLFDEDIT
| Q4 25 | -7.1% | -147.3% | ||
| Q3 25 | — | -414.6% | ||
| Q2 25 | 15.1% | — | ||
| Q1 25 | 1.4% | -1028.6% | ||
| Q4 24 | 17.1% | -167.6% | ||
| Q3 24 | 323.0% | -90998.4% | ||
| Q2 24 | 5.8% | -11804.3% | ||
| Q1 24 | -20.8% | -4558.9% |
资本支出强度CLFDEDIT
| Q4 25 | 2.9% | 0.2% | ||
| Q3 25 | 2.0% | 5.7% | ||
| Q2 25 | 0.8% | 0.0% | ||
| Q1 25 | 5.1% | 2.4% | ||
| Q4 24 | 7.0% | 1.8% | ||
| Q3 24 | 71.4% | 4788.5% | ||
| Q2 24 | 2.5% | 681.1% | ||
| Q1 24 | 5.3% | 164.8% |
现金转化率CLFDEDIT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.93× | — | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
